Atypical parkinsonism, or the so-called Parkinson-plus syndromes, does not respond to dopaminergic or other therapies that are used for Parkinson's disease. The 2 most common of these conditions are ...

University of Florida researchers have led a multicenter study demonstrating that Automated Imaging Differentiation for Parkinsonism (AIDP), a machine-learning method using magnetic resonance imaging ...

A machine learning model differentiated Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. AUROCs and predictive values for distinguishing Parkinson's from mimics were ...

With several fluid biomarkers for Alzheimer’s in hand, the search is on for counterparts in Parkinson’s disease and dementia with Lewy bodies (DLB). Four new papers introduce two candidates: DOPA ...

Parkinson's disease affects millions of people around the world. There are actually 10 million people on a worldwide scale that have the neurodegenerative disorder, according to the Parkinson's ...